000			01731 a2200457 4500
005			20250516173111.0
264		0	_c20150402
008			201504s 0 0 spa d
022			_a0210-5705
024	7		_a10.1016/j.gastrohep.2013.07.008 _2doi
040			_aNLM _beng _cNLM
100	1		_aGonzález-Artacho, Cristina
245	0	0	_a[Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents]. _h[electronic resource]
260			_bGastroenterologia y hepatologia _cJan 2014
300			_a23-4 p. _bdigital
500			_aPublication Type: Letter
650	0	4	_aAdalimumab
650	0	4	_aAdenine _xanalogs & derivatives
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal, Humanized _xtherapeutic use
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aAzathioprine _xtherapeutic use
650	0	4	_aCrohn Disease _xcomplications
650	0	4	_aFemale
650	0	4	_aHepatitis B, Chronic _xcomplications
650	0	4	_aHepatitis C, Chronic _xcomplications
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aOrganophosphonates _xtherapeutic use
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aViral Load
650	0	4	_aViremia _xcomplications
650	0	4	_aVirus Activation
700	1		_aRodríguez Sicilia, María José
700	1		_aAlegría-Motte, Carlos
700	1		_aGómez García, María
773	0		_tGastroenterologia y hepatologia _gvol. 37 _gno. 1 _gp. 23-4
856	4	0	_uhttps://doi.org/10.1016/j.gastrohep.2013.07.008 _zAvailable from publisher's website
999			_c23142369 _d23142369